↓ Skip to main content

Type 2 Diabetes Mellitus Intersects With Pancreatic Cancer Diagnosis and Development

Overview of attention for article published in Frontiers in oncology, August 2021
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter
2 X users

Readers on

mendeley
44 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Type 2 Diabetes Mellitus Intersects With Pancreatic Cancer Diagnosis and Development
Published in
Frontiers in oncology, August 2021
DOI 10.3389/fonc.2021.730038
Pubmed ID
Authors

Xiaoye Duan, Weihao Wang, Qi Pan, Lixin Guo

Timeline

Login to access the full chart related to this output.

If you don’t have an account, click here to discover Explorer

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 44 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 44 100%

Demographic breakdown

Readers by professional status Count As %
Student > Master 6 14%
Student > Bachelor 5 11%
Student > Ph. D. Student 5 11%
Professor 2 5%
Student > Doctoral Student 2 5%
Other 3 7%
Unknown 21 48%
Readers by discipline Count As %
Medicine and Dentistry 7 16%
Biochemistry, Genetics and Molecular Biology 6 14%
Nursing and Health Professions 2 5%
Pharmacology, Toxicology and Pharmaceutical Science 2 5%
Business, Management and Accounting 1 2%
Other 4 9%
Unknown 22 50%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 25 February 2022.
All research outputs
#21,578,649
of 26,491,397 outputs
Outputs from Frontiers in oncology
#11,968
of 23,231 outputs
Outputs of similar age
#324,073
of 426,318 outputs
Outputs of similar age from Frontiers in oncology
#638
of 1,352 outputs
Altmetric has tracked 26,491,397 research outputs across all sources so far. This one is in the 10th percentile – i.e., 10% of other outputs scored the same or lower than it.
So far Altmetric has tracked 23,231 research outputs from this source. They receive a mean Attention Score of 3.1. This one is in the 27th percentile – i.e., 27% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 426,318 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 13th percentile – i.e., 13% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 1,352 others from the same source and published within six weeks on either side of this one. This one is in the 37th percentile – i.e., 37% of its contemporaries scored the same or lower than it.